NCT06536556View on ClinicalTrials.gov

Effects of a Single Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: Comparison of Paclitaxel vs Paclitaxel + Trastuzumab vs Paclitaxel + Carboplatine: the PROTECT-06 Bis Study

Active, not recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 2, 2024

Primary Completion Date

September 6, 2025

Study Completion Date

September 6, 2025

Conditions
Breast Cancer
Interventions
OTHER

First Assessment

pre-treatment assessment

OTHER

Second Assessment

4 days post-treatment assessment

Trial Locations (1)

67033

Institut de cancérologie Strasbourg europe, Strasbourg

All Listed Sponsors
lead

Institut de cancérologie Strasbourg Europe

OTHER